Nuvectis Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $26,796 |
Gross Profit | 13,398 | |||
EBITDA | -7,462 | -6,334 | -5,568 | -6,449 |
EBIT | -6,595 | -5,568 | -6,449 | |
Net Income | -7,462 | -6,334 | -5,332 | -6,248 |
Net Change In Cash | 0 | 0 | 0 | 26,796 |
Free Cash Flow | -4,494 | -3,367 | -4,174 | -2,465 |
Cash | 35,442 | 26,793 | 29,864 | 18,533 |
Basic Shares | 22,719 | 21,366 | 19,937 | 19,495 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $149 | $0 |
Gross Profit | -22,897 | -19,085 | -12,894 | |
EBITDA | -19,000 | -22,897 | -18,936 | -12,890 |
EBIT | -19,847 | -21,897 | -19,234 | -12,894 |
Net Income | -19,000 | -22,260 | -18,787 | -12,886 |
Net Change In Cash | 0 | 0 | 149 | 0 |
Cost of Revenue | 14,251 | |||
Free Cash Flow | -12,247 | -15,954 | -13,559 | -9,504 |
Cash | 18,533 | 19,126 | 19,993 | 5,742 |
Basic Shares | 17,113 | 15,556 | 12,657 | 12,717 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.44 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.27 |
